The presence of this mutation has such a dramatic effect on long-term survival that astrocytomas are then often further classified as either IDH-mutant or IDH-wildtype [14,15,16,17,18,19]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).